
Seagen (SGEN) Gets Early FDA Nod for Tivdak in Cervical Cancer (Revised)
Published on September 22, 2021
The FDA grants accelerated nod to Seagen (SGEN) and Genmab's Tivdak for treating adult patients with recurrent/metastatic cervical cancer with disease...
